Allecra Therapeutics
develops and commercializes novel antibiotics for the treatment of multi drug-resistant bacterial infections... Read moreAllecra Therapeutics
develops and commercializes novel antibiotics for the treatment of multi drug-resistant bacterial infections... Read more
CEO
Add
News
Jun 25, 2024
Pharmabiz
Allecra Therapeutics: Allecra & Acino ink licensing and supply agreement for Allecra's novel antibiotic Exblifep in GCC countries and South Africa
Feb 28, 2024
PMLiVE
Allecra Therapeutics: FDA approves Allecra's combination antibiotic Exblifep for complicated UTIs
Jan 27, 2024
Medthority
Allecra Therapeutics: Advanz Pharma receives positive CHMP opinion for Exblifep (cefepime/enmetazobactam) to treat
complicated urinary tract infections,
Jun 27, 2023
FinanzNachrichten
Allecra Therapeutics: Allecra Therapeutics Submits New Drug Application to the U.S. FDA for EXBLIFEP for the Treatment of Complicated Urinary Tract Infections
Oct 09, 2022
Medthority
Allecra Therapeutics: Final phase III ALLIUM data in is published in JAMA: Cefepime/Enmetazobactam met criteria for superiority. -Allecra Therapeutics .
Oct 05, 2022
FinanzNachrichten
Allecra Therapeutics: Allecra Therapeutics Publishes Final Phase 3 ALLIUM Data in JAMA: Cefepime/Enmetazobactam Met Criteria for Superiority
Jan 22, 2022
Global Legal Chronicle
Allecra Therapeutics: Allecra Therapeutics' Licensing Agreement with Advanz Pharma
Jan 13, 2022
BioSpace
Allecra Therapeutics: Allecra Therapeutics and ADVANZ PHARMA Sign Exclusive License and Supply Agreement for Allecra's Antibiotic Cefepime/enmetazobactam in Europe
Dec 23, 2020
Global Legal Chronicle
Allecra Therapeutics: Allecra Therapeutics' Licensing Agreement with Shanghai Haini Pharmaceutical
Feb 27, 2020
Pharmabiz
Allecra Therapeutics: Allecra Therapeutics announces positive results from phase 3 ALLIUM trial of Exblifepfor to treat complicated urinary tract infections
Allecra Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10